Back to today’s briefing

Story perspectives

Rapid Micro Faces Investor Scrutiny Amid Insider Sales

2/22/2026

50 6 Full Breakdown

Summary

Story summary

Key Information: Rapid Micro Biosystems, Inc. (NASDAQ: RPID) faces investor scrutiny over insider activity.
Chief Operating Officer John Addington Wilson sold 5,403 shares, reducing his stake by 1.63%.
The stock trades near $3.89 and is above key moving averages.
The company holds a $172 million market cap and solid balance sheet metrics.
Analysts rate it Hold with an $8.00 price target, implying potential pharmaceutical growth.

1 of 1

Story summary

Key Information: Rapid Micro Biosystems, Inc. (NASDAQ: RPID) faces investor scrutiny over insider activity.
Chief Operating Officer John Addington Wilson sold 5,403 shares, reducing his stake by 1.63%.
The stock trades near $3.89 and is above key moving averages.
The company holds a $172 million market cap and solid balance sheet metrics.
Analysts rate it Hold with an $8.00 price target, implying potential pharmaceutical growth.